Pearls and Prep

MDD with Mixed Features: What Do You Reach for When SSRIs Stop Making Sense?

26 min · 19 de may de 2026
Portada del episodio MDD with Mixed Features: What Do You Reach for When SSRIs Stop Making Sense?

Descripción

Today, we're diving into the wild world of Major Depressive Disorder with mixed features—yeah, it's as tricky as it sounds! We’re chatting about how this gray area in mental health can really throw a wrench in the works for both patients and clinicians. Did you know that around one in five folks with MDD has these mixed features? That's a number that gets my attention! We're breaking down the challenges, like figuring out if a patient’s racing thoughts are part of their depression or something else entirely. Plus, we're throwing in some insights on how to handle these cases without making things worse—because let's face it, nobody wants to be the one who accidentally triggers a manic episode. So grab your favorite snack, kick back, and let’s get into the nitty-gritty of managing MDD with mixed features! 32 MDD with Mixed Features: What Do You Reach for When SSRIs Stop Making Sense? Pearls and Prep pearlsandprep@mail.com https://patreon.com/PearlsandPrep?utm_medium=unknown&utm_source=join_link&utm_campaign=creatorshare_creator&utm_content=copyLink Diving into the deep end of mental health, we tackle the slippery slope of Major Depressive Disorder with mixed features. You know, that tricky little beast that makes diagnosing a real head-scratcher. We’re talking about a patient, let’s call her Polly (MOCK PATIENT) who’s juggling depression with some manic symptoms. Picture this: she's on Zoloft, feeling more wired than a kid on Halloween candy, and yet, the gloom still lingers. So, what gives? We explore the nuances of mixed features that can masquerade as just plain old depression. I'll share some insight on the DSM-5 criteria that helps differentiate between the two, and trust me, it’s not as simple as it sounds. The episode really shines a light on the importance of careful diagnosis. We don't want to end up treating Polly’s depression while inadvertently sending her spiraling into mania. It’s a balancing act, folks! And then, we dive into treatment strategies, highlighting Latuda — the not-so-secret weapon in our pharmacological arsenal. This medication has shown some pretty impressive results in clinical trials for mixed features, and we unpack why it's a solid choice to avoid the pitfalls of traditional SSRIs. Let’s just say, we’re not about to throw Polly to the wolves without a proper plan! Get ready for a wild ride through the gray areas of mental health as we unravel the complexities of mixed features in Major Depressive Disorder. We kick things off by introducing a patient named Polly, who’s caught in a whirlwind of depression and those pesky manic symptoms. I mean, how do you treat someone who’s feeling low but also has moments of racing thoughts and irritability? It’s like trying to solve a Rubik's Cube while blindfolded! We dig into the DSM-5 criteria and some stats that reveal how common these mixed features really are. Spoiler alert: they’re more prevalent than you might think! I share some clinical anecdotes and the challenges that come with diagnosing mixed features versus straightforward depression. And then we get into the nitty-gritty of treatment. Forget the one-size-fits-all approach! We chat about Latuda and its role in stabilizing mood without triggering a manic episode. It’s all about finding that sweet spot and ensuring our patients get the care they need. This isn’t just a lecture; it’s a practical chat that aims to turn you from a good clinician into a great one! Strap in for a rollercoaster of insights on the often-murky waters of Major Depressive Disorder with mixed features. We’re going to meet Polly, our case study for the day, who’s navigating the complexities of mood disorders like a pro, but without the right treatment, she might just be left in the lurch. The episode kicks off with an exploration of the DSM-5 criteria for diagnosing mixed features and how it’s a game-changer in treatment planning. We’ll dissect Polly’s symptoms and figure out why she’s still feeling down despite being on Zoloft. Is it time to switch gears and consider a different approach? We walk through the potential dangers of SSRIs in patients with mixed features and why they might not be the best bet. Enter Latuda — our hero of the day! We’ll break down the science behind how it works, why it’s effective, and how it can help stabilize those mixed symptoms without sending patients into hyperdrive. Plus, you’ll get tips on how to support your patients better and ensure they aren’t just another statistic in the mental health world. This episode is packed with practical advice and a sprinkle of humor to keep things light while we tackle serious topics. Takeaways: * In outpatient practice, major depressive disorder with mixed features is super common and tricky to spot. * About 1 in 5 patients with major depressive disorder has mixed features, which can complicate treatment. * When treating MDD with mixed features, SSRIs can be risky as they may trigger manic episodes. * Latuda is a promising option for MDD with mixed features, showing significant efficacy in studies. Companies mentioned in this episode: * Zoloft * Latuda * Vralar This podcast uses the following third-party services for analysis: Podcorn - https://podcorn.com/privacy

Comentarios

0

Sé la primera persona en comentar

¡Regístrate ahora y únete a la comunidad de Pearls and Prep!

Empezar

2 meses por 1 €

Después 4,99 € / mes · Cancela cuando quieras.

  • Podcasts exclusivos
  • 20 horas de audiolibros / mes
  • Podcast gratuitos

Todos los episodios

86 episodios

Portada del episodio ADHD or Anxiety? The One Question That Changes Everything

ADHD or Anxiety? The One Question That Changes Everything

There are two kinds of clinicians—the ones who follow algorithms, and the ones who understand the “why.” Patients know the difference. Know the WHY! Join our clinical library today on PATREON! 👉 https://www.patreon.com/PearlsandPrep [https://www.patreon.com/PearlsandPrep] Alright, folks, buckle up! Today we're diving into the wild world of ADHD evaluations, and trust me, it’s gonna be a ride. Meet Carly, a 31-year-old (mock patient) law student who's convinced she’s got ADHD because, well, life in law school can be a total bear. But hold up! Before we slap that label on her, we gotta sift through some serious stuff about fear, anxiety, and how they can totally masquerade as ADHD. We’ll chat about the sneaky anchoring bias that could lead us down the wrong path and how understanding what’s really competing for Carly's attention is key. So, grab your notepads, because this one's packed with pearls of wisdom for all you future clinicians out there! 32 ADHD or Anxiety? The One Question That Changes Everything Pearls and Prep pearlsandprep@mail.com https://patreon.com/PearlsandPrep?utm_medium=unknown&utm_source=join_link&utm_campaign=creatorshare_creator&utm_content=copyLink Carly's journey into the world of ADHD evaluation brings some serious food for thought. She's a 31-year-old law student, and she's pretty sure she's been dealing with ADHD her whole life. But here's the kicker: she’s only now asking for help because her law school workload has her drowning, and she’s desperate for some extra time on her exams. The episode dives into the nuances of diagnosing ADHD, especially in women who often fly under the radar. Our host warns us about the infamous anchoring bias—where we jump to conclusions based on the first piece of information we get, which in Carly's case is the ADHD sign flashing like a neon billboard. But wait—there's more! As we peel back the layers, we learn that Carly's symptoms might be more aligned with generalized anxiety disorder (GAD) than ADHD. The host emphasizes the importance of digging deeper into what’s really going on in Carly's head instead of just slapping a label on her. This episode serves up some solid pearls on how to ask the right questions and think critically about mental health diagnoses. Buckle up, because this episode is a wild ride through the diagnostic jungle! Carly's evaluation unfolds like a detective story, with clues leading us this way and that. Is it ADHD, GAD, or maybe a bit of both? Our host takes us through the diagnostic process with the finesse of a seasoned sleuth. We explore Carly's childhood—she's always been a bit anxious, crying before school and getting stomach aches before tests. But did these symptoms morph into something more serious under the pressures of law school? Or is she experiencing an adjustment disorder? The episode gives us a front-row seat to the complexity of mental health, where one diagnosis can overlap with another, leading to a tangled web of worries and fears. The takeaway? We need to be thorough, compassionate, and patient when evaluating someone’s mental health. We learn that the right questions can uncover the truth, and understanding the intricacies of anxiety versus attention issues is crucial. As we wrap up, our host really hammers home the point that understanding the ‘how’ and ‘why’ of mental health diagnoses is what separates the good clinicians from the great ones. We’re not just here to hand out labels; we’re here to empower our patients with knowledge. Carly's case highlights the importance of not just diagnosing but also explaining our rationale to patients. It’s about building trust and ensuring they feel heard. This episode isn’t just informative; it’s a call to action for all of us in the mental health field to dig deeper and keep our minds open. Tune in, because this isn't just for the pros; it's for anyone who wants to understand the complexities of mental health better! Takeaways: * Understanding the complexities of ADHD vs. anxiety is crucial for accurate diagnosis. * Always consider the patient's history and symptoms beyond initial assumptions during evaluations. * The question of what competes for a patient's attention reveals a lot about their mental state. * It's important to avoid bias in diagnosing mental health issues, especially with common disorders like ADHD. Links referenced in this episode: * patreon.com/pearlsandprep [https://patreon.com/pearlsandprep] This podcast uses the following third-party services for analysis: Podcorn - https://podcorn.com/privacy

Ayer34 min
Portada del episodio 4 Ways Personality Disorders Can Disrupt Even the Best Treatment Plans. And what we Can Do About It.

4 Ways Personality Disorders Can Disrupt Even the Best Treatment Plans. And what we Can Do About It.

There are two kinds of clinicians—the ones who follow algorithms, and the ones who understand the “why.” Patients know the difference. Know the WHY! Join our clinical library today on PATREON! 👉 https://www.patreon.com/PearlsandPrep [https://www.patreon.com/PearlsandPrep] Personality disorders are like hidden icebergs, and they can really sink your treatment ship if you’re not careful. We dive into four key ways these disorders can derail your efforts, often without you even realizing it. From alliance ruptures to sneaky symptoms that masquerade as other issues, we've got the scoop on how to spot and tackle these challenges. Plus, we chat about the importance of understanding your patients’ backgrounds and how that shapes their personalities. So, buckle up, because we’re about to dish out some pearls of wisdom that’ll help you navigate these tricky waters with style! 32 4 Ways Personality Disorders Can Disrupt Even the Best Treatment Plans. And what we Can Do About It. Pearls and Prep pearlsandprep@mail.com https://patreon.com/PearlsandPrep?utm_medium=unknown&utm_source=join_link&utm_campaign=creatorshare_creator&utm_content=copyLink Diving deep into the world of personality disorders, we tackle some hefty topics that might just rock your mental health boat. Our main squeeze here is the four sneaky ways these disorders can totally derail your treatment plans. You might think you know your patient’s struggles, but hold on, because it turns out a whopping 45% of folks with major depressive disorder also have a personality disorder hanging out in the background. Who knew? We break down the definition of personality disorders, making it clear that they aren't just quirky behaviors but serious issues that can mess with your therapeutic vibe. From alliance ruptures to trust issues, we get into the nitty-gritty of how these disorders morph into real obstacles. So, if you've got patients showing up with symptoms that just won't quit, it might be time for a little detective work into their personality dynamics. Trust me, it's worth it. This episode is packed with pearls of wisdom that might just save your sanity and improve your patient relationships. Takeaways: * Personality disorders can really mess up your treatment plans if you don't recognize them. * It's super crucial to assess for personality disorders in your patients, especially when treatments aren't working. * Your relationship with your patient is like a vital sign, check in on it regularly. * Therapeutic alliances can get rocky, so be ready to manage those relationship dynamics with care. Links referenced in this episode: * patreon.com/pearlsandprep [https://patreon.com/pearlsandprep] This podcast uses the following third-party services for analysis: Podcorn - https://podcorn.com/privacy

7 de jun de 202626 min
Portada del episodio What If Your Most Stable Patient Is Developing Your Biggest Blind Spot?

What If Your Most Stable Patient Is Developing Your Biggest Blind Spot?

There are two kinds of clinicians—the ones who follow algorithms, and the ones who understand the “why.” Patients know the difference. Know the WHY! Join our clinical library today on PATREON! 👉 https://www.patreon.com/PearlsandPrep [https://www.patreon.com/PearlsandPrep] We're diving into tardive dyskinesia today, and trust me, this is something you definitely want to know about. We’re breaking down what it is, how to spot it, and what to do if you find it hanging around. By the end of our chat, you’ll be so pumped with knowledge you might just turn into a walking medical exam! We’ve got some juicy pearls to share that’ll help you navigate this tricky topic like a pro. So, grab your favorite snack and let's get into it, ‘cause this episode is packed with insights that’ll keep you sharp in practice! 32 What If Your Most Stable Patient Is Developing Your Biggest Blind Spot? Pearls and Prep pearlsandprep@mail.com https://patreon.com/PearlsandPrep?utm_medium=unknown&utm_source=join_link&utm_campaign=creatorshare_creator&utm_content=copyLink Tardive dyskinesia is the name of the game today, and trust me, it's a big deal. We dive deep into this movement disorder, which is basically a party crasher brought on by certain meds like Haldol. Picture this: Joe, our fictional patient, walks in with some serious lip smacking and tongue darting moves that even he doesn’t notice, but his wife Rosa? She's worried. We break down how to recognize tardive dyskinesia, the tricky business of treating it without making things worse, and why simply lowering the dose isn’t always the fix we think it is. By the end of our chat, you’ll be ready to do an AIMS exam on anyone who crosses your path—seriously, you’ll be that empowered! Plus, we sprinkle in some practical tips on how to manage these symptoms, keeping Joe’s medication intact without sending him spiraling back into psychosis. So grab a seat, kick back, and let’s get into the nitty-gritty of keeping our patients safe while navigating the wild world of psychiatry. Takeaways: * Tardive dyskinesia is a movement disorder caused by long-term use of antipsychotics, particularly Haldol. * It's super important to monitor patients on antipsychotics for tardive dyskinesia regularly to catch it early. * Lowering or stopping antipsychotics can make tardive dyskinesia worse, so be careful with that. * VMAT2 inhibitors can help manage tardive dyskinesia without compromising antipsychotic effectiveness. * Doing an Ames exam is crucial for identifying tardive dyskinesia in patients, so don’t skip it! * Second-generation antipsychotics can also cause tardive dyskinesia, even if they seem less risky. Links referenced in this episode: * patreon.com/pearlsandprep [https://patreon.com/pearlsandprep] Companies mentioned in this episode: * Haldol * Prozac * Zoloft * Adderall * Risperdal * Olanzapine * Zyprexa * Abilify * Seroquel * clozapine This podcast uses the following third-party services for analysis: Podcorn - https://podcorn.com/privacy

6 de jun de 202624 min
Portada del episodio Tardive Dyskinesia Risk Factors: One of These Should Jump Off the Page

Tardive Dyskinesia Risk Factors: One of These Should Jump Off the Page

There are two kinds of clinicians—the ones who follow algorithms, and the ones who understand the “why.” Patients know the difference. Know the WHY! Join our clinical library today on PATREON! 👉 https://www.patreon.com/PearlsandPrep [https://www.patreon.com/PearlsandPrep] We're diving into the world of tardive dyskinesia today, and let me tell ya, it's a biggie! We're breaking down the nitty-gritty of assessing risk and figuring out who’s most at risk for these pesky movements. Think of tardive dyskinesia as that friend who shows up late and makes a scene—totally not cool, right? We’re throwing some scenarios your way to test your skills on picking the highest risk patient. Spoiler alert: age is the real MVP when it comes to risk factors, so stick around as we unravel this mystery and arm you with the knowledge to kick some serious butt in your practice! 32 Tardive Dyskinesia Risk Factors: One of These Should Jump Off the Page Pearls and Prep pearlsandprep@mail.com https://patreon.com/PearlsandPrep?utm_medium=unknown&utm_source=join_link&utm_campaign=creatorshare_creator&utm_content=copyLink Get ready to dive deep into the world of tardive dyskinesia, my friends! This episode kicks off with a warm welcome and straight into the meat of the matter. We’re tackling the complexities of assessing risk related to tardive dyskinesia, and trust me, it’s a ride. The host brilliantly breaks down the term itself, drawing from ancient Greek to make it stick in our minds. Picture this: tardive means ‘late,’ and dyskinesia refers to ‘abnormal movement.’ With some cheeky humor about tardy friends and the challenges they present, we’re not just learning; we’re also chuckling along the way. As we get into the nitty-gritty, we’re faced with a thought-provoking board bomb challenge where we have to figure out which patient is at the highest risk for developing tardive dyskinesia among a group of five. This isn’t just a walk in the park; it’s a real brain-teaser! Each patient has a unique profile, and we learn how age, medications, and duration of treatment play a crucial role in the risk factors. The host emphasizes that age is the single greatest risk factor, which might surprise some listeners, especially since many don’t associate tardive dyskinesia with older adults on antidepressants. So, buckle up as we navigate through the dos and don’ts of psychiatric medications and how they relate to this condition, all while maintaining a lighthearted vibe and engaging commentary. By the end of the episode, we’re not just walking away with knowledge; we’re armed with pearls of wisdom about how to monitor and advocate for patients at risk of tardive dyskinesia. Expect to be empowered with practical tips on using the Abnormal Involuntary Movement Scale (AIMS) and a reminder that our patients need us to be their advocates. Let’s just say, this episode is both enlightening and fun, making it a must-listen for anyone in the field of psychiatry! Takeaways: * Tardive dyskinesia means late abnormal movements, kinda like being fashionably late to a party. * Age is the biggest deal when it comes to developing tardive dyskinesia, so watch out for those older folks! * Antipsychotics can be tricky; knowing their doses and risks could save you a headache later. * Using the AIMS assessment tool helps you keep track of tardive dyskinesia symptoms and their severity. Links referenced in this episode: * patreon.com/pearlsandprep [https://patreon.com/pearlsandprep] Companies mentioned in this episode: * Eminem * Moby * Risperidol * Abilify * Seroquel * Clozapine * Zyprexa This podcast uses the following third-party services for analysis: Podcorn - https://podcorn.com/privacy

5 de jun de 202615 min
Portada del episodio The Benzo Boarding Pass: The Pharmacokinetics of Fear at 35,000 Feet

The Benzo Boarding Pass: The Pharmacokinetics of Fear at 35,000 Feet

There are two kinds of clinicians—the ones who follow algorithms, and the ones who understand the “why.” Patients know the difference. Know the WHY! Join our clinical library today on PATREON! 👉 https://www.patreon.com/PearlsandPrep [https://www.patreon.com/PearlsandPrep] We're diving into the wild world of flying phobias today, and trust me, it's a bumpy ride! Our buddy Aaron (mock patient) is sweating bullets over his upcoming 17-hour flight from New York to Sydney, and he's looking for some serious help to conquer that fear. We're gonna unpack all things psychopharmacology to figure out the best meds for him, keeping in mind the right onset and duration so he doesn’t freak out mid-air. We'll chat about the good, the bad, and the downright ugly when it comes to anxiety meds like Xanax and Klonopin. So, buckle up, because we’re about to get into the nitty-gritty of how to keep our pal calm while soaring through the clouds! 32 The Benzo Boarding Pass: The Pharmacokinetics of Fear at 35,000 Feet Pearls and Prep pearlsandprep@mail.com https://patreon.com/PearlsandPrep?utm_medium=unknown&utm_source=join_link&utm_campaign=creatorshare_creator&utm_content=copyLink Taking a deep dive into the world of flying phobias, this episode serves up a mix of psychopharmacology and practical advice for dealing with anxiety in the skies. We're introduced to a hypothetical patient, Aaron, who's gearing up for a marathon flight from New York to Sydney—16 hours of pure anxiety for someone terrified of flying. The conversation flows as we explore various medications and their effects, focusing on the importance of choosing the right one for Aaron's needs. Spoiler alert: Xanax is a no-go for this long haul. With a blend of humor and expert knowledge, we break down the pharmacological properties that make certain medications work better for Aaron's situation, while also keeping it real with the challenges of managing anxiety. It’s a fun, informative ride filled with insights into how to best support patients with flying phobias and the importance of understanding medication dynamics—because when you're 35,000 feet up, timing is everything! Takeaways: * This episode dives into the anxiety of flying, focusing on a patient named Aaron who has a serious phobia about air travel, which is super relatable for many of us. * We explore the importance of understanding medication onset and duration, especially when dealing with anxiety meds for long flights like Aaron's 17-hour trek from New York to Sydney. * Klonopin is highlighted as a better choice for flight anxiety due to its longer duration and slower onset, compared to other options like Xanax, which can be too quick and cause rebound anxiety. * The podcast emphasizes that while medications can help, they aren't a cure-all; understanding the patient's fear and potentially incorporating therapy is super important for long-term solutions. * Flying can be a real challenge for anxiety sufferers, and this episode provides insightful tips for managing those nerves while also keeping humor in the mix. * Remember, it's all about timing when it comes to taking these meds; knowing when they kick in can make or break a flight experience for someone like Aaron. Companies mentioned in this episode: * Xanax * Valium * Klonopin * Ativan This podcast uses the following third-party services for analysis: Podcorn - https://podcorn.com/privacy

4 de jun de 202624 min